NUS1
Dehydrodolichyl diphosphate synthase complex subunit NUS1
Also known as: C6orf68, MGC7199, NgBR, NGBR_HUMAN, TANGO14
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96E22
- Gene
- NUS1
- Ensembl
- ENSG00000153989
- Chromosome
- 6
- Canonical length
- 293 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Vesicles,Plasma membrane
OverviewNCBI Gene
This gene encodes a type I single transmembrane domain receptor, which is a subunit of cis-prenyltransferase, and serves as a specific receptor for the neural and cardiovascular regulator Nogo-B. The encoded protein is essential for dolichol synthesis and protein glycosylation. This gene is highly expressed in non-small cell lung carcinomas as well as estrogen receptor-alpha positive breast cancer cells where it promotes epithelial mesenchymal transition. This gene is associated with the poor prognosis of human hepatocellular carcinoma patients. Naturally occurring mutations in this gene cause a congenital disorder of glycosylation and are associated with epilepsy. A knockout of the orthologous gene in mice causes embryonic lethality before day 6.5. Pseudogenes of this gene have been defined on chromosomes 13 and X. [provided by RefSeq, May 2017]
Canonical amino-acid sequenceUniProt
293 residues, UniProt reviewed canonical sequence.
>Q96E22|NUS1
1 MTGLYELVWR VLHALLCLHR TLTSWLRVRF GTWNWIWRRC CRAASAAVLA PLGFTLRKPP
61 AVGRNRRHHR HPRGGSCLAA AHHRMRWRAD GRSLEKLPVH MGLVITEVEQ EPSFSDIASL
121 VVWCMAVGIS YISVYDHQGI FKRNNSRLMD EILKQQQELL GLDCSKYSPE FANSNDKDDQ
181 VLNCHLAVKV LSPEDGKADI VRAAQDFCQL VAQKQKRPTD LDVDTLASLL SSNGCPDPDL
241 VLKFGPVDST LGFLPWHIRL TEIVSLPSHL NISYEDFFSA LRQYAACEQR LGKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NUS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 57 nTPM
Expression across tissuesHPA
Tissue
- cervix: 57 nTPM
- thyroid gland: 33 nTPM
- liver: 30 nTPM
- salivary gland: 29 nTPM
- parathyroid gland: 28 nTPM
- epididymis: 27 nTPM
Single-cell type
- mucous neck cells: 95 nCPM
- monocyte progenitors: 93 nCPM
- extravillous trophoblasts: 88 nCPM
- pdcs: 83 nCPM
- plasma cells: 81 nCPM
- syncytiotrophoblasts: 79 nCPM
Immune cell
- plasmacytoid DC: 3.8 nTPM
- non-classical monocyte: 2.5 nTPM
- basophil: 1.9 nTPM
- MAIT T-cell: 1.9 nTPM
- NK-cell: 1.9 nTPM
- memory CD8 T-cell: 1.8 nTPM
Brain region
- choroid plexus: 26 nTPM
- hypothalamus: 21 nTPM
- basal ganglia: 19 nTPM
- cerebral cortex: 19 nTPM
- midbrain: 19 nTPM
- hippocampal formation: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NUS1.
Disease | AllUniProt
Conditions NUS1 is implicated in, by any mechanism.
- Congenital disorder of glycosylation 1AA (CDG1AA) MIM:617082
- Intellectual developmental disorder, autosomal dominant 55, with seizures (MRD55) MIM:617831
Disease | GeneticClinVar
86 pathogenic / likely-pathogenic of 506 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital disorder of glycosylation, type IAA
- Intellectual disability, autosomal dominant 55, with seizures
- NUS1-related disorder
- Inborn genetic diseases
- NUS1-related epilepsy-myoclonus-ataxia syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- -1.4
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cell differentiation
- cholesterol homeostasis
- dolichyl diphosphate biosynthetic process
- dolichyl monophosphate biosynthetic process
- positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis
- positive regulation of cell migration involved in sprouting angiogenesis
- regulation of intracellular cholesterol transport
- vascular endothelial growth factor signaling pathway
Molecular functions
- ditrans,polycis-polyprenyl diphosphate synthase [(2E,6E)-farnesyl diphosphate specific] activity
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Decaprenyl diphosphate synthase-like
- Decaprenyl diphosphate synthase-like superfamily
- Putative undecaprenyl diphosphate synthase
- Dehydrodolichyl diphosphate synthase complex subunit Nus1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NUS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NUS1 as an antibody target. Whether an autoantibody or antibody against NUS1 could matter depends on whether native NUS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NUS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NUS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...